i don't see how they are related at all.
esti is developing a percutaneous transmyocardial revascularization
technique (in english, you thread a catheter into the heart, and
shoot holes in the heart muscle with a laser, supposed to improve
vascularization / blood flow into areas of heart that have poor blood
flow). Eson makes a diagnostic device, which images the interior
of coronary arteries. The Esti device was tested as an adjunct to
bypass surgery. I suppose if the TMR improves the results of
bypass surgery as much as is claimed, then more people would be in
line to get angiograms, which could possibly increase use of Eson's
device. On the other hand, the main use of eson's device would
appear to be as an aid in reaming out coronary arteries, so that
you can avoid bypass surgery. if TMR improves bypass surgery to the
point that balloons, stents, and intracoronary lasers are less effective, then Eson would have trouble. all told, hard to predict
any relation between the two companies.
Ira |
